The researchers found that several types of blood pressure medications—especially ACE inhibitors, beta-blockers, ...

“ Psoriasis is an inflammatory skin disorder, due to an overactive immune system,” said Dr. Omar Noor. “That over active immune system produces inflammation in the skin that causes the skin to develop ...

Spots can also look very different depending on your skin tone. Some pink, red, or brown spots are more obvious on fair to ...

Affiliate content. Discover the best products for arthritis in hands, including supplements, creams, and tools designed to ...

Arcutis Biotherapeutics wants to eliminate a terrible trade-off for patients with skin conditions. Arcutis stock investors are taking notice.

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis in a skin biopsy, according to a press release.

Discover a study that investigates spesolimab, a monoclonal antibody that has been approved as the first GPP-specific therapy ...

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...